Improving the current diabetic macular oedema screening
programme
I Wong1; R Wong2; R Gangwani1;
V Chong3; R Kawasaki4
1 Department of Ophthalmology, LKS
Faculty of Medicine, The University of Hong Kong
2 Department of Ophthalmology, The Hong
Kong Eye Hospital
3 Department of Ophthalmology, Oxford
University, UK
4 Department of Public Health, Yamagata
University Graduate School of Medical Science, Japan
1. The current diabetic retinopathy screening
strategy is very effective at detecting maculopathy, but it has low
sensitivity and positive predictive value.
2. Under the current strategy, up to 87.1% of patients referred to ophthalmologists for maculopathy screening were found to be false positives.
3. Three newly proposed screening strategies were compared with the current strategy in terms of sensitivity index and cost-effectiveness.
4. Strategy D that incorporated macular optical coherence tomography for all patients into the current strategy was most cost-effective.
2. Under the current strategy, up to 87.1% of patients referred to ophthalmologists for maculopathy screening were found to be false positives.
3. Three newly proposed screening strategies were compared with the current strategy in terms of sensitivity index and cost-effectiveness.
4. Strategy D that incorporated macular optical coherence tomography for all patients into the current strategy was most cost-effective.